Sab Biotherapeutics Inc (SABS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 30,134 | -15,311 | -5,197 | -34,105 | -22,711 |
| Depreciation Amortization | 2,267 | 1,525 | 759 | 4,556 | 3,789 |
| Accounts receivable | N/A | N/A | 34 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,158 | 822 | 684 | 923 | 333 |
| Other Working Capital | 3,631 | 2,007 | 1,065 | -2,299 | -415 |
| Other Operating Activity | -65,189 | -3,992 | -5,142 | -3,367 | -5,757 |
| Operating Cash Flow | $-27,999 | $-14,949 | $-7,797 | $-34,292 | $-24,760 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1 | 1 | 1 | -337 | -282 |
| Purchase Of Investment | -129,992 | -123 | -71 | -37,446 | -36,138 |
| Sale Of Investment | 9,991 | 9,991 | 4,742 | 25,821 | 15,126 |
| Investing Cash Flow | $-120,000 | $9,869 | $4,671 | $-11,962 | $-21,293 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 516 | N/A |
| Debt Repayment | -106 | -70 | -35 | -132 | -98 |
| Common Stock Issued | N/A | N/A | N/A | 20 | 20 |
| Other Financing Activity | 168,447 | -278 | -139 | -1,577 | -1,312 |
| Financing Cash Flow | $168,341 | $-348 | $-174 | $-1,173 | $-1,390 |
| Exchange Rate Effect | 184 | 222 | 43 | -241 | 48 |
| Beginning Cash Position | 8,898 | 8,898 | 8,898 | 56,566 | 56,566 |
| End Cash Position | 29,425 | 3,692 | 5,640 | 8,898 | 9,171 |
| Net Cash Flow | $20,527 | $-5,206 | $-3,258 | $-47,668 | $-47,395 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,999 | -14,949 | -7,797 | -34,292 | -24,760 |
| Capital Expenditure | N/A | N/A | N/A | -337 | -282 |
| Free Cash Flow | -27,999 | -14,949 | -7,797 | -34,629 | -25,042 |